We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

92 hedge funds and large institutions have $265M invested in Tvardi Therapeutics in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 41 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 8

128% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 18

123% more call options, than puts

Call options by funds: $507K | Put options by funds: $227K

81% more capital invested

Capital invested by funds: $146M → $265M (+$119M)

23% more funds holding

Funds holding: 75 → 92 (+17)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
92
Holders Change
+17
Holders Change %
+22.67%
% of All Funds
2.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
41
Reduced
18
Closed
8
Calls
$507K
Puts
$227K
Net Calls
+$280K
Net Calls Change
-$184K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$51M
2
SAM
Sectoral Asset Management
Quebec, Canada
+$19M
3
Jennison Associates
Jennison Associates
New York
+$7.97M
4
BIT
BlackRock Institutional Trust
California
+$4.88M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.69M

Top Sellers

Rank Fund Capital Flow
1
WSA
Wall Street Associates
California
-$4.53M
2
TAM
Tiverton Asset Management
Delaware
-$3.94M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.93M
4
TC
TFS Capital
Pennsylvania
-$1.53M
5
MCM
Moore Capital Management
New York
-$1.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
26
California Public Employees Retirement System
California
$2.04M – – –
BIM
27
Bogle Investment Management
Massachusetts
$2.04M +$2.65M +3,959 New
SKK
28
Shepherd Kaplan Krochuk
Massachusetts
$1.64M -$395K -590 -16%
SGAM
29
Smith Group Asset Management
Texas
$1.63M -$669 -1 -0%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$1.6M +$934K +1,396 +81%
TCIM
31
TIAA CREF Investment Management
New York
$1.43M +$34.1K +51 +2%
ARTA
32
A.R.T. Advisors
New York
$1.38M +$1.79M +2,676 New
DCM
33
DAFNA Capital Management
California
$1.34M -$621K -928 -26%
BA
34
BlackRock Advisors
Delaware
$1.26M +$106K +159 +7%
Deutsche Bank
35
Deutsche Bank
Germany
$1.17M +$1.45M +2,161 +1,929%
AQR Capital Management
36
AQR Capital Management
Connecticut
$1.09M +$1.11M +1,663 +369%
PAMU
37
Pictet Asset Management (UK)
United Kingdom
$1.08M +$1.4M +2,094 New
MCTP
38
MPAM Credit Trading Partners
Ohio
$1.07M +$1.39M +2,082 New
BCM
39
Bridgeway Capital Management
Texas
$1.05M – – –
GCP
40
GSA Capital Partners
United Kingdom
$1M +$1.31M +1,953 New
BIM
41
BlackRock Investment Management
Delaware
$980K +$199K +298 +19%
TC
42
TFS Capital
Pennsylvania
$948K -$1.53M -2,283 -55%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$938K +$97.7K +146 +9%
Citadel Advisors
44
Citadel Advisors
Florida
$867K +$1.13M +1,685 New
TI
45
Trexquant Investment
Connecticut
$819K +$1.07M +1,593 New
EI
46
EAM Investors
California
$794K +$1.03M +1,543 New
RFC
47
Russell Frank Company
Washington
$768K +$1M +1,494 New
BWP
48
Baldwin Wealth Partners
Massachusetts
$743K – – –
Alyeska Investment Group
49
Alyeska Investment Group
Illinois
$590K +$768K +1,147 New
Morgan Stanley
50
Morgan Stanley
New York
$531K +$423K +632 +158%
1
2
3 4

TVRD Hedge Fund Activity: Q3 2015 in Review

92 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q3 2015, worth a combined $265M — up 81% from $146M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new TVRD positions and 8 closed out — a net gain of 17 holders — while 41 added to existing stakes and 18 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $51M. The largest seller was Wall Street Associates, cutting an estimated $4.53M.

  • 92 institutional investors held Tvardi Therapeutics (TVRD) as of Q3 2015, up from 75 in Q2 2015.
  • Funds reported $265M of Tvardi Therapeutics stock for Q3 2015, up 81% quarter-over-quarter.
  • 25 funds opened new Tvardi Therapeutics positions in Q3 2015 and 8 closed out, a net change of +17 holders.
  • The largest Tvardi Therapeutics buyer in Q3 2015 was Fidelity Investments, an estimated $51M added.
  • The largest Tvardi Therapeutics seller in Q3 2015 was Wall Street Associates, an estimated $4.53M sold.

Based on aggregated 13F filings for Q3 2015.